medigraphic.com

2003, Number 6

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2003; 41 (6)

Use and Abuse of Home Oxygen Prescription

Méndez R, Vázquez SBP, Díaz VM, Barquera S, Múgica HeJJ

Language: Spanish
References: 38
Page: 473-480
PDF size: 169.73 Kb.


ABSTRACT

Objective: to determine adequate prescription of Domiciliary supplementary oxygen therapy prescription (DSOTP) at La Raza National Medical Center (RNMC). Methods: patient files on DSOTP during 1998 were identified from RNMC and information with regard to criteria for making decisions was collected from medical records. An adequate prescription of DSOTP was defined if ≥ two respiratory insufficiency (RI) criteria existed. Results: during the period, 38 461 DSOTP prescriptions were given to 2198 users. The highest percentage of prescription was for COPD (44 %). A total of 42 % of cases did not include gasometry in medical records and 9 % had normal oxygen levels. Only 38 % had ≥ two RI parameters. Conclusion: information obtained showed non-existence of adherence to international guidelines of DSOTP use in 42 % of study sample. Spreading and adhering to guidelines for prescription in these cases could produce significant savings to the national health system.


REFERENCES

  1. 1. Tiep BL. Long-term home oxygen therapy. Clin Chest Med 1990;11:505-521.

  2. 2. Petty TL. Respiratory therapy techniques. En: Hodgkin JE, Petty TL, editors. Chronic obstructive pulmonary disease. Current concepts. Philadelphia, USA: WB Saunders; 1987. p. 92-98.

  3. 3. Nocturnal Oxygen Therapy Trial Group. Con-tinuous of nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease. Ann Intern Med 1980;93:391-398.

  4. 4. Report of The Medical Research Council Working Party. Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981;1:681-686.

  5. 5. Pepin JL, Barijhoux CE, Deschaux C, Brambilla C. Long-term oxygen therapy at home. Compliance with medical prescription and effective use of therapy ANTADIR Working Group on Oxygen Therapy, Association Nationale de Traitement a Domicile des Insuffisants Respiratories. Chest 1996;109:1144-1150.

  6. 6. Krop HD, Block JA, Cohen E. Neurophychological effect of continuous oxygen therapy in the aged. Chest 1977;72:737-743.

  7. 7. Heaton RK, Grant I, Mc Sweeny AJ, et al. Phy-sologic effect of continuous and nocturnal oxygen therapy in hypoxemic chronic obstructive pulmo-nary disease. Arch Inter Med 1983;143:1943-1947.

  8. 8. Walters MI, Edwards PR, Waterhouse JC, Howard P. Long-term domiciliary oxygen therapy in chronic obstructive pulmonary disease. Thorax 1993;48: 1170-1177.

  9. 9. Honig EG, Ingram RH. Chronic bronchitis, emphy-sema and airways obstruction. En: Isselbacher KJ, Braunwald E, Wilson JD, editors. Harrison’s princi-ples of internal medicine. Thirteenth edition. USA: McGraw Hill; 1998. p. 1376-1386.

  10. O’Donohue WJ. Home oxygen therapy. Clin Chest Med 1997;18:535-543.

  11. George RB, San-Pedro GS. Chronic obstructive pulmonary disease: clinical course and management. En: Fishman AP, Elías JA, Fishman JA, editors. Fishman’s pulmonary disease and disorders. Third edition. New York: McGraw-Hill; 1998. p. 683-696.

  12. Petty TL. Oxígeno en el hogar: revolución en el cuidado de sujetos con neumopatía obstructiva crónica avanzada. Clin Med Norteam 1990;3:729-743.

  13. Rico-Méndez FG, Escobedo A, Alba C, Valencia E, Ochoa G. Costo directo del tratamiento de la enfer-medad pulmonar obstructiva crónica en el Instituto Mexicano del Seguro Social. Rev Higiene 2002;1: 119-123.

  14. Rico-Méndez FG, Barquera S, Cabrera A, Escobedo L, Ochoa G, Massey R. Bronchial asthma from 1991-1996 health care cost in Mexico. Analysis of trends from 1991-1996 with information from the Mexican Institute of Social Security. Invest Allergol Clin Immunol 2000;10:334-341.

  15. Rico-Méndez FG, Gómez C, Meneses L, Múgica J, Pérez-Gúzman C, Ocha G, Escobedo C, Ocaña S. Valores gasométricos en población geriátrica. Análisis en dos diferentes altitudes (resultado de un proyecto nacional) Rev Inst Nal Enf Resp 1998;11: 25-29.

  16. Rico-Méndez FG, Urias-Almada P, Barquera C, Ochoa J, Padilla N, Meneses G, Espinosa P. Valores espirométricos y gasométricos en una población geriátrica sana, a diferentes alturas sobre el nivel del mar, en la República Mexicana. Estudio multi-céntrico. Rev INER 2001;14:90-99.

  17. Departamento de Contraloría Interna Delegación 2 Valle de México IMSS.

  18. Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease (GOLD). HLBI/WHO Workshop Report 2001 (Suppl);2701:1-1004.

  19. Espinoza-Pérez JL, Fuentes M, Rico-Méndez FG. Bronquitis crónica-enfisema pulmonar. En: Rico- Méndez FG, Villanueva-Seres CM, Argüero R, edi-tores. Neumología: conceptos clínico-radiológicos. Primera edición. México: Trillas; 1989. p. 137-145.

  20. ATS. Statement. Am J Resp Crit Care Med 1995; 152:S77-S120.

  21. Conference Report. Further recommendations for prescribing, reimbursement, technical development and research in long-term oxygen therapy. Am J Resp Crit Care Med 1994;150:875-877.

  22. American College of Chest Physicians, National Heart Lung and Blood Institute. National Con-ference of Oxygen Therapy. Chest 1984;86:234-247.

  23. Fulner JD, Snider GL. ACCP-NHLBI National Conference on Oxygen Therapy. Respir Care 1992; 37:918-922.

  24. Sánchez-Agudo L, Cornudella R, Estopa-Miró R, Molinos-Martín L, Cervera-Pieras E. Normativa para la indicación y empleo de la oxigenoterapia continua domiciliaria. Arch Bronconeumol 1998;34:87-94.

  25. Barnes P. Managing chronic obstructive pulmonary disease. London: SP Science Press; 1999. p. 1-18.

  26. Setting The Stage. Global COPD Conference. 14-17 November 2001, Jkos, Grece.

  27. Early detection and management of COPD. Guide-lines from the National COPD Awareness Panel (NCAP). J Respir Dis September 2000.

  28. Cienfuegos A, Escribano PM, López A, Salama B. Alta prevalencia de oxigenoterapia crónica domi-ciliaria, con bajo porcentaje de indicación incorrecta en un área de salud de Madrid. Valoración del uso correcto. Arch Bronconeumol 2000;36:139-145.

  29. INFRA de México. Base de datos.

  30. Ruiz-Argüelles GJ, Sánchez-Medal L, Loría A, Piedras J, Córdova MS. Red cell indices in normal adults residing at altitudes from sea level to 2670 meters. Am J Hematol 1980;8:265-271.

  31. Morrison D, Skwarsky K, Mc Nee W. Review of the prescription on domiciliary long-term oxygen therapy in Scotland. Thorax 1995;50:1103-1105.

  32. Munilla E, Carrizo S, Hernández A, Vela J, Marín JM. Oxigenoterapia continua domiciliaria en Zara-goza: estudio transversal a domicilio. Arch Bronco-neumol 1996;32:59-63.

  33. Blue Cross and Blue Shield of Alabama Office of the Inspector General, Office of Audit. Review of medical necessity for oxygen concentrators. Common Identification A-04-87-02000, 1988

  34. O’Donohue WJ, Plummer AL. Magnitude of usage and cost of home oxygen therapy in the United States. Chest 1995;107:301-302.

  35. Parra O, Palau M, Barrueco M, Amilibia J, León A, Oltra J, Escarrabill J. Efectos de la visita domi-ciliaria en el cumplimiento de la prescripción de la oxigenoterapia domiciliaria. Estudio multicéntrico. Arch Bronconeumol 2001;37:206-211.

  36. Agencia de Evaluación de Tecnologías Sanitarias del Instituto de Salud. Ministerio de Sanidad y Consumo. España; 1995.

  37. Conference Report. Further recommendation for prescribing and supplying long-term oxygen therapy. Am Rev Resp Dis 1988;138:745-747.

  38. SEP Task Group. Recommendations for long-term oxygen therapy. Eur Resp J 1989;2:160-164.




2020     |     www.medigraphic.com